CADL – candel therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Candel Therapeutics, Inc. (NASDAQ: CADL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer [Yahoo! Finance]
Candel Therapeutics reports Q3 results [Seeking Alpha]
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Form 4 Candel Therapeutics, For: Nov 21 Filed by: Tak Paul Peter
Form 10-Q Candel Therapeutics, For: Sep 30
Form 8-K Candel Therapeutics, For: Nov 14
Form 4 Candel Therapeutics, For: Nov 06 Filed by: Aguilar Laura K.
Form 4 Candel Therapeutics, For: Oct 30 Filed by: Aguilar Laura K.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.